RECALL: Ranitidine products recalled because of a nitrosamine impurity

Announcements

This month, a new update has been released regarding ranitidine drugs. Pharmascience Inc. recalls certain lots of prescription and over-the-counter ranitidine as a precaution Pharmascience Inc. is recalling 13 lots of prescription and over-the-counter ranitidine drugs (150 mg tablets) after tests found NDMA, a nitrosamine impurity, at below but close to the accepted level. Please refer to the Affected Products table below for detailed information on the recalled lots.

Click here for more information.


Comments are closed.


















  •  




  • RSS Hot Canada Deals

  • Recent Comments

  • Did You Know?

    Smart Canucks is Canada's first Canadian shopping deals blog and has been operating since 2005!



  • Join Mailing List

    Categories

    Pages

    Archives

    Find Deals by Brand!